#161922

SK-N-BE(2)-C Cell Line

Cat. #161922

SK-N-BE(2)-C Cell Line

Cat. #: 161922

Availability: 8-10 weeks

Organism: Human

Tissue: Brain

Model: Tumourigenic

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: June L. Biedler, Barbara A. Spengler

Institute: Memorial Sloan-Kettering Cancer Center (MSK)

Primary Citation: Ciccarone et al. 1989. Cancer Research. 49: 219-225. PMID: 2535691.

Tool Details
Applications
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: SK-N-BE(2)-C Cell Line
  • Cancer: Neurological cancer
  • Cancers detailed: Neuroblastoma
  • Parental cell: SK-N-BE(2)
  • Organism: Human
  • Gender: Male
  • Tissue: Brain
  • Donor: This cell line is a subclone of the SK-N-BE(2) neuroblastoma cell line. The parental cell line was established in 1972 from a metastatic site (bone marrow) in a two-year-old Caucasian male with malignant neuroblastoma.
  • Morphology: Neuroblast
  • Growth properties: Adherent
  • Model: Tumourigenic
  • Description: SK-N-BE(2)-C is a clonal subline of the SK-N-BE(2) neuroblastoma cell line. Like the parental cell line, these cells display MYCN amplification. Treatment with trans-retinoic acid differentiates these cells into a distinct neuronal phenotype. These cells display high levels of tyrosine hydroxylase activity and dopamine-b-hydroxylase activity.
  • Application: 3D cell culture; Immunology; Neuroscience
  • Biosafety level: 1
  • Additional notes: BE(2)-C cells have a reported saturation density of greater than 5 X 105 cells/cm2. The cells grow as clusters of flattened neuroblastic cells with occasional fine cell processes (neurites). Unlike the parent line, they generally do not detach and float.

Applications

  • Application: 3D cell culture; Immunology; Neuroscience

Handling

  • Growth medium: 1:1 mixture of EMEM:F12 Medium, then supplemented with FBS to a final concentration of 10%
  • Temperature: 37° C
  • Atmosphere: 5% CO2 in air
  • Shipping conditions: Dry Ice
  • Storage medium: Complete growth medium supplemented with 5% (v/v) DMSO
  • Storage conditions: Vapor phase of liquid nitrogen
  • Str profiling: Amelogenin: XCSF1PO: 10D13S317: 11D16S539: 9,11D5S818: 12D7S820: 9,10TH01: 6TPOX: 11vWA: 18D3S1358: 19D21S11: 30,32.2D18S51: 16Penta_E: 14,18Penta_D: 13,14D8S1179: 13,14FGA: 22,25D19S433: 12,13D2S1338: 23

Related Tools

  • Related tools: SK-N-BE(2)

References

  • Qiao et al. 2012. Biochemical and Biophysical Research Communications. 424: 421-426. PMID: 22766505.